We are 2-(4-bromo-phenyl)-1(9)H-benzo[d]imidazo[1,2-a]imidazole CAS:30513-47-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Related News: Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.N,N'-Bis-boc-1-guanylpyrazole Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.4-cloro-6,7-bis (2-metoxietoxi) quinazolina CAS:183322-18-1 The fine and functional chemicals sector provides new growth drivers.4-amino-1H-imidazol-5-carboxamida CAS:360-97-4 The fine and functional chemicals sector provides new growth drivers.Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.
Product Name | |
---|---|
(2S,3R,5R)-5-Chloro-2-(((4-methylbenzoyl)oxy)-methyl)tetrahydrofuran-3-yl 4-methylbenzoate | View Details |
Platinum (IV) Oxide Anhydrous Cas:1314-15-4 | View Details |
2-Amino-4-chloro-3-nitropyridine | View Details |